Cefmetazole occasionally prolongs the prothrombin time. The mechanism is considered to be because of (i) inhibition of vitamin K metabolism, (ii) a lack of vitamin K, and (iii) low vitamin K stores. We report the death of a 93-year-old woman who was administered cefmetazole and exhibited a prolonged prothrombin time. When using cefmetazole in elderly patients, PT-INR should be monitored every few days.
| INTRODUCTION
Cefmetazole is frequently used in Japan. This antibiotic is commonly used for intra-abdominal infections, PID, and surgical prophylaxis because of its activity against aerobic gram-negative rods and anaerobic bacteria. Furthermore, in Japan, cefmetazole is an option to refrain from using carbapenem in treating noncomplicated urinary tract infection caused by ESBL-producing Enterobacteriaceae.
1 Although adverse effects, such as hypoprothrombinemia and disulfiram-like reactions, have been described, the physician would not be able to sufficiently recognize these effects.
| CASE REPORT
A totally dependent 93-year-old woman who lived in a nursing home was admitted to our hospital because of a 2 week history of appetite loss and a 1 day history of fever and unconsciousness. She was admin- The third mechanism is the low vitamin K stores of such patients. The risk factor for antibiotic-induced hypoprothrombinemia is vitamin K deficiency because of elderly patient, malnutrition, renal disease, and liver disease. Patients who were administered cefmetazole are usually forced to restrict their food intake because this antibiotic is frequently used for intra-abdominal infections. Therefore, when cefmetazole is administered to elderly patients, it is considered as an antibiotic that tends to lead to hypoprothrombinemia.
Cefmetazole-induced hypoprothrombinemia is considered uncommon. One of 118,138 patients was reported to have developed hypoprothrombinemia through cefmetazole treatment; this was assessed by a postmarketing surveillance study in Japan. 3 There are three English articles and two Japanese articles assessing adult cases, and only 11 cases, including our case, have been described in total (Table 1 ). The average time of nine cases, except two not described in detail, from initiation of antibiotic therapy to diagnosing hypoprothrombinemia or bleeding was 8.1 days (range, 2-20 days). In contrast, the average time was reported to be 5.7 days (range, 2-15 days) when the cephalosporins were used in 17 cases. 4 Eight of the nine cases were recognized as hypoprothrombinemia with bleeding; almost all cases survived after being administered vitamin K supplements. Furthermore, hypoprothrombinemia is preventable by vitamin K prophylaxis if administered once or three times weekly. 
| CONCLUSIONS
The adverse drug reactions should be avoided, but cannot cope when we do not know it. We should know that cefmetazole may induce hypoprothrombinemia and should monitor PT-INR every few days when cefmetazole is used in elderly patients.
